KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Total Non-Current Liabilities (2020 - 2026)

AbCellera Biologics filings provide 7 years of Total Non-Current Liabilities readings, the most recent being $321.7 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 30.88% to $321.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $321.7 million through Mar 2026, up 30.88% year-over-year, with the annual reading at $325.7 million for FY2025, 42.96% up from the prior year.
  • Total Non-Current Liabilities hit $321.7 million in Q1 2026 for AbCellera Biologics, down from $325.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $328.0 million in Q2 2025 and bottomed at $159.8 million in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $237.8 million, with a median of $227.9 million recorded in 2024.
  • The largest annual shift saw Total Non-Current Liabilities surged 106.45% in 2022 before it rose 3.45% in 2024.
  • AbCellera Biologics' Total Non-Current Liabilities stood at $189.3 million in 2022, then rose by 14.5% to $216.8 million in 2023, then increased by 5.12% to $227.9 million in 2024, then surged by 42.96% to $325.7 million in 2025, then dropped by 1.23% to $321.7 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Total Non-Current Liabilities are $321.7 million (Q1 2026), $325.7 million (Q4 2025), and $323.2 million (Q3 2025).